openPR Logo
Press release

Heart Failure Software Market - Trends and Opportunities for the Industry by 2024

02-22-2017 02:24 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Heart Failure Software Market - Trends and Opportunities for

The global heart failure software market is growing significantly due to changing healthcare system. Rising demand for monitored care for individual health has in turn increased demand for heart failure software. Technological advancements and increased accessibility to personal healthcare systems are some factors projected to drive growth of the heart failure software market.

Obtain the PDF enclosing the Future Market Analysis of Heart Failure Software at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16289

Rising need for continuous health assessment and dynamic advancements in technology have introduced various applications of clinical decision support system such as heart failure software system. Heart failure software enables management of cardiac patients safely and efficiently. It offers support to patients in cardiac activity monitoring and analyzing risk zone of patients with cardiac diseases. Documenting, assessment, activity monitoring, referrals, communicating between physicians for treatment, follow up, etc. are activities carried out through heart failure software. Thus, it is deployed by hospitals, cardiac clinics and other clinical facilities for continuous assessment and monitoring of patients. With patient numbers increasing due to the combined effects of improved survival after heart attack and an ageing population, the management of heart failure patients will continue to have a significant impact on healthcare resources. Thus, driving growth of the heart failure software market. Continuous monitoring of cardiac condition helps improve treatment compliance, improves control on symptoms, decrease patients clinical visits, improves patient outcome, enables detailed investigation for the cardiac symptoms, etc.

Rising health awareness, increasing demand for continuous health monitoring, and shifting consumer preference towards a healthy lifestyle has led the heart failure software market to upsurge substantially. Technological advancements have led to the emergence of various health monitoring devices such as remote patient monitoring, activity tracker and wearable medical devices that in turn are expected to drive growth of the heart failure software market. Moreover, rising need for continuous monitoring of health in lifestyle diseases such as cardiac arrest, hypertension, etc. has led to increase in demand for heart failure software.

Increasing demand for access to patient health records (PHR/ PHI) is the important factor leading to Heart Failure Software market growth. Awareness is the important factor for increasing the adoption rate for Heart Failure Software. Thus, government and various international organization across the globe are being involved in various initiatives undertaken to increase the awareness about the monitoring devices. Various government and non – government organization continuously operates in development of advanced healthcare solutions by offering funds, leveraging technology and skills. For an instance, according to study published by Wolters Kluwers in 2016, the use of clinical decision support system for heart failure patients has shown improved health outcomes in patients and decrease in readmissions.

In terms of type of model, heart failure software market is categorized into knowledge based and non – knowledge based. Knowledge based heart failure software was observed with relatively significant demand than the other. However, the challenges reported in the type of models is the interoperability of different systems or platforms existing in hospital and clinical setup. Moreover, increasing advancement in personal medical devices is anticipated to exert positive impact on overall heart failure software market.

In terms of delivery mode, heart failure software market is segmented into web-based, on-premises and cloud-based systems. Cloud based systems is the fastest growing segment in the market.

In terms of end users, hospital segment is expected to account for major share in heart failure software market, due to increasing adoption of electronic health records (EHR) and remote patient monitoring system. Rising awareness about personal health amongst the population is expected to drive growth of the consumer segment over the near future.

By geography, due to high adoption rate of technology and improved healthcare policies has made North America to occupy the significant market share in heart failure software market, followed by rest developed markets like Europe. US have been the largest market across the globe. The dominance of North America is due to factors like well-established healthcare and technology infrastructure, rising awareness level, and extensive internet coverage across the region, etc. However, Asia Pacific is anticipated to grow at significant rate, following to developed regions like North America and Europe. Increase in disposable income, rising population, increasing demand for wearable monitoring health devices, increasing government intervention for development of healthcare infrastructure are the major factors leading to drive the Asia Pacific Market. In addition, increasing penetration of virtual healthcare systems like tele-health, e-health and m-health applications has led the significant positive impact on developing regions like Asia Pacific. Thus Asian market is reported with significant new entrants in the heart failure software market compared to rest of the world. China and India are anticipated as favorable market for new entrants in heart failure software sector.

Read the Present Market Trend of Heart Failure Software at: http://www.transparencymarketresearch.com/heart-failure-software-market.html

Most of the players in heart failure software market are focused to develop technologically advance and cost efficient system on the virtue of offering solution to customers like comfortable, compact, easy to use solution, etc. Due to rising competition in the market, the companies adopt various policies including strategic alliances, forward and backward integration, new product development, mergers and acquisitions, etc. in order to sustain the business in the market. The Major players reported in the market include Cerner Corporation, 4S Information Systems Ltd., Axis Clinical Software, Inc., CitiusTech Inc., etc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Failure Software Market - Trends and Opportunities for the Industry by 2024 here

News-ID: 445717 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an